Drug Discovery & DevelopmentOriginal article
FDA issues final PDUFA meeting guidance, expands use of written responses
RegulatoryNeutral
AI Analysis
Summary
The FDA has finalized updated guidelines for PDUFA meetings with drug sponsors and applicants, incorporating changes from the draft guidance published in September 2023. The new guidelines expand the use of written responses in the meeting process.
Outcome Details
FDA finalized new guidelines for PDUFA meetings between FDA and sponsors/applicants for drug and biological product development and review
Importance:3/10
Sentiment:
0.00
FDAPDUFAguidanceregulatorydrug development
Read the original article
Published by Drug Discovery & Development on August 18, 2026 7:20 PM